Physician profile

Preet Bagi

Gastroenterology (Internal Medicine) · Anderson, SC

NPI 1245432145

$641.09

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$19.29

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $155.09 2019
Si-Bone, INC. $139.38 2019-2020
Takeda Pharmaceuticals U.S.A., INC. $83.10 2019
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $64.03 2019-2024 Xifaxan
Pfizer INC. $47.66 2019
Janssen Biotech, INC. $35.48 2019
Intercept Pharmaceuticals, INC. $31.83 2019
Braintree Laboratories, INC. $27.80 2019
Endo Pharmaceuticals INC. $24.36 2019
Nestle Healthcare Nutrition INC. $17.30 2022
Qol Medical, LLC $15.06 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Preet Bagi

$641.09

in general payments reported 2019-2025

Years
2019-2024
Top company
Abbvie INC.

https://glasscript.com/doctor/1295536/preet-bagi

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.